PAREA @pareascience.bsky.social

Big news from today’s General Assembly! Want the full story? Check out our new BlueSky page tinyurl.com/yc5hh7sj Adios, X!

Last week, we warmly welcomed the Italian Society for Psychedelic Medicine (SIMEPSI) and the Ukrainian Psychedelic Research Association (UPRA) to our Community Supporters network! We look forward to our continued collaboration! tinyurl.com/3efaz5k5

PAREA has co-signed a statement by @MentalHealthEur calling on the European Commission, Parliament and Member States to deliver tangible follow-through on promises made for mental health care. Organisations can still co-sign until Dec 10: tinyurl.com/ycx4y7mm

On Saturday, PAREA attended @BelgiumSociety ‘s annual symposium, speaking about access to psychedelic medicines. The event showcased the current landscape of psychedelic therapy and research in Belgium. We were grateful for the opportunity to connect with the Belgian community!

We are proud today to be a part of the first Italian conference discussing the clinical use of psychedelics, in Rovereto. We will present on the “Legal Status of Psychedelics and Its Impact on Research and Development.”. addictionsciencelab.unitn.it/conference

Our October Insights newsletter is here! Some highlights: Welcoming our newest PAREA team member; Our commentary on the need for dedicated mental health funding in EU R&I; Engagement in discussions on brain health at the UN General Assembly in New York. tinyurl.com/insights-Octob…

We're thrilled to welcome Francisca Silva to our team joining us today as a Project Officer! A recent EMA trainee and neuroscientist by training, she has a dual MSc in Brain and Mind Sciences from UCL and Sorbonne Université, along with a BSc from the Maastricht Science Program

PAREA's issued a commentary on the high-level expert report on EU R&I programmes! We highlight the urgent need for enhanced mental health funding and support, advocating for a dedicated EU mission for mental health, similar to the Cancer Mission view.flodesk.com/emails/668800c…

Happy Mental Health Day! PAREA is in Geneva for the WHO Mental Health Forum. Mental health is often neglected, but global progress is very encouraging. This year's theme focuses on the link between mental health and work. Safe, healthy workplaces are essential.

The @PsyPal_EU project was recently highlighted at the Hopkins-Oxford Psychedelic Ethics (HOPE) Summit in Washington, D.C, and represented by Tadeusz Hawrot of @PareaScience. Read more about the event here: palliativeprojects.eu/psypal/2024/10…

Members of the EU4Health Civil Society Alliance, including PAREA, published a letter sharing concerns regarding the nomination of the next Commissioner for Health! The letter calls for health to be given the importance it deserves : eu4health.eu/letter-to-ursu…

PAREA's Executive Director is featured in an @euronews article discussing the potential of psychedelic therapies in Europe. The interest is growing, but challenges remain before these treatments can reach patients. euronews.com/health/2024/09…

PAREA's founder spoke earlier this month at the launch of the European Commission’s Thematic Network, "Towards an EU Coordination Plan for the Brain." run by the European Brain Council. Great to see it covered by Medscape! Read more: shorturl.at/WigdT

PsychedeliCare is officially registered as a European Citizens' Initiative by the European Commission. Details: psychedelicare.eu/news/ PAREA has supported this initiative from the start. After its 2025 launch, we’ll be collecting 1 million signatures to have our asks considered.

PAREA submitted input to the Public Consultation on the Strategic R&I Agenda for the forthcoming EU Partnership for Brain Health organized as part of the Coordination & Support Action BrainHealth. Consultation: tinyurl.com/mucnfxsr PAREA submission: tinyurl.com/mtcn99j4

PAREA regrets FDA refusal of new drug approval for MDMA-assisted therapy for PTSD, which may deprive people with PTSD of an effective treatment option Read our full news release here: tinyurl.com/NewsRelease-FD…

@Drug_science @PareaScience @MindMedicineAU position statement regarding the forthcoming @US_FDA hearing of @MAPS MDMA submission #MDMA4PTSD drugscience.org.uk/allaying-the-f…

Today, we announced key updates on psychedelics in Europe: In a just published ENG version of its report, the Dutch State Committee endorses MDMA-assisted therapy for PTSD, and EMA publishes a comprehensive report on psychedelics. See full release here: tinyurl.com/news-NL-EMA

Today, we are welcoming a new PAREA Community Supporter: Foundation for Therapeutic Advancement and Innovation with Psychedelics. TAIP is an Estonian org that advances science-based approaches to using psychedelics in contemporary therapeutic practices sataip.ee/home

Within the #EU4HealthCivilSocietyAlliance, #PareaScience, as a member, supports the call for the appointment of a Vice-President for Health, Wellbeing, and Social Rights in a letter to @vonderleyen. Explore further: eu4health.eu/appeal-to-pres… @EPHA_EU @PareaScience @vonderleyen